Assess the Value of Specialty Drugs with Robert Popovian, Senior Director, Pfizer | Last Chance to Save $700 is this Friday

Last Chance for MAXIMUM Savings is this Friday, June 27th

Register Now to Save up to $700 with the code: XP1968BLOG

Assess the Value of Specialty Drugs with Robert Popovian, Senior Director, Pfizer

Managing costs and determining the value of specialty drugs is key in understanding if the specialty model is sustainable. Hear from Robert Popovian, Senior Director, US Government Relations, Pfizer at IIR’s all-new Specialty Pharmacy Collaboration Summit, as he addresses the optimal methodologies to assess the value and cost proposition of specialty drugs in the evolving payment policy environment.

Learn How To:
• Define quality measures for specialty medicines
• Ensure global payment models which encapsulate all costs and outcomes including those for pharmaceuticals
• Develop measures of quality and value that are relevant to patients


Download the brochure for the full agenda and speaker details.

Don’t miss out! This Friday, June 27th is your last chance to save up to $600! Plus take an EXTRA $100 off when you use the code XP1968BLOG. Click here to register or call 888-670-8200 to register.

Q&A with Amy Ramazio of GlaxoSmithKline – A Speaker at IIR’s Gross-to-Net Accounting Forum

At IIR's 2nd Annual Gross-to-Net Accounting Pharmaceutical Manufacturers, Amy Ramazio, Finance Director at GlaxoSmithKline will be the Big Pharma Chairperson, in our all new tailored discussion groups for your specific company size and function!

Below Amy sat down to do a quick Q&A session with us...enjoy!


Q&A:

1. How feasible is collaboration between managed markets, commercial, government programs and Finance?

Successful collaboration will largely depend on the particular individuals involved.  The key is for everyone to have an enterprise view.

2. Key questions to ask before investing and building an automated GTN system?

- What functionality is most important to your organization?
- How much are you willing to invest?
- When do you need the system to go live?

3. How to accrue and forecast patient/ payer related items? What critical/essential information is required and what aspects you can’t afford to overlook.

Forecasting and accruals are typically based on past history with some adjustments where there are specific changes expected in the future.  Having information to develop these adjustments is critical and could include: segment lives and expected trends, TRX data, formulary changes, legislation changes.   


To hear more from Amy, please join us in Philadelphia, June 17-18 for the 2nd Annual Gross-to-Net Accounting Forum. Plus register with the code XP1911BLOG to receive $100 off the current rate!

Register Now!